Abstract
The aim of this study is to explore the survival rate and risk factors of mortality in patients with late-onset systemic lupus erythematosus (SLE) in a large cohort. Clinical presentations, disease activity, organ damage scores, autoantibody profile, and mortality data were obtained retrospectively from late-onset SLE patients (onset age ≥50 years) diagnosed between 1995 and 2009. The risk factors of organ damage were evaluated by the chi-square test and logistic regression. The cumulative rate of survival was calculated by Kaplan–Meier method, and factors predictive of mortality were studied by Cox proportion hazard regression model. A total of 158 patients (132 female and 26 male) were studied. The average onset age was 58.66 ± 6.38 years and mean disease duration was 63.85 ± 48.17 months. One hundred and four patients had organ damage at the time of data analysis. Hematological system and kidney involvement were most common. Central nervous system involvement was relatively rare. In univariate logistic analysis, associations were found between SLE disease activity index (SLEDAI) at diagnosis (OR = 1.133, P = 0.001); renal involvement (OR = 2.441, P = 0.009) and edema (OR = 2.812, P = 0.003) were associated with organ damage. And SLEDAI at diagnosis (OR = 1.103, P = 0.034) was independent factor for organ damage in multivariate logistic regression. During the follow-up, 64 patients (51 female and 13 male) died. Five-, 10-, and 15-year survival rates were 80.4, 56.5, and 31.7 %, respectively. Median survival time was 123 months. The analysis of Cox proportion hazard regression model showed that age at disease onset (OR = 1.069, P = 0.002), compliance of medical care (OR = 3.282, P = 0.001), and SLEDAI at diagnosis (OR = 1.091, P = 0.003) were independent risk factors of mortality. Late-onset SLE has a poor long-term prognosis. Infection is the major cause of death in patients with late-onset lupus. Disease activity, medical care, and onset age are strongly related to death of late-onset SLE.
Similar content being viewed by others
References
Ho CT, Mok CC, Lau CS, Wong RW (1998) Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 57:437–440
Costallat LT, Coimbra AM (1994) Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 12:603–607
Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC (2004) Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 83:348–359
Bertoli AM, Alarcón GS, Calvo-Alén J, Fernández M, Vilá LM, Reveille JD, Study Group LUMINA (2006) Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical (corrected) features, course and outcome in patients with late-onset disease. Arthritis Rheum 54:1580–1587
Maddison P, Farewell V, Isenberg D et al (2002) The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 29:913–917
Lalani S, Pope J, de Leon F, Peschken C, Members of CaNIOS/1000 Faces of Lupus (2010) Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 Faces of Lupus study. J Rheumatol 37:38–44
Ward MM, Polisson RP (1989) A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum 32:1226–1232
Kasitanon N, Magder LS, Petri M (2006) Predictors of survival in systemic lupus erythematosus. Med (Baltimore) 85:147–156
Cervera R, Khamashta MA, Font J et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Med (Baltimore) 82:299–308
Blanco FJ, Gómez-Reino JJ, de la Mata J et al (1998) Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 7:159–163
Contreras G, Lenz O, Pardo V et al (2006) Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 69:1846–1851
Rabbani MA, Habib HB, Islam M et al (2009) Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus 18:848–855
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Gladman DD, Goldsmith CH, Urowitz MB et al (1994) Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 21:1468–1471
Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369
Appenzeller S, Pereira DA, Costallat LT (2008) Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study. Lupus 17:1023–1028
Koh ET, Boey ML (1994) Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol 21:1463–1467
Mok CC, Mak A, Chu WP, To CH, Wong SN (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Med (Baltimore) 84:218–224
Zonana-Nacach A, Yañez P, Jiménez-Balderas FJ, Camargo-Coronel A (2007) Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus. Lupus 6:997–1000
Nossent J, Cikes N, Kiss E et al (2007) Current causes of death in systemic lupus erythematosus in Europe, 2000–2004: relation to disease activity and damage accrual. Lupus 16:309–317
Cook RJ, Gladman DD, Pericak D, Urowitz MB (2000) Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 27:1892–1895
Rovenský J, Tuchynová A (2008) Systemic lupus erythematosus in the elderly. Autoimmun Rev 7:235–239
Pu SJ, Luo SF, Wu YJ, Cheng HS, Ho HH (2000) The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 9:96–100
Lazaro D (2007) Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment. Drugs Aging 24:701–715
Ward MM, Pyun E, Studenski S (1996) Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 156:1337–1344
Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 22:1265–1270
Ward MM, Pyun E, Studenski S (1995) Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 38:274–283
Gladman DD (1996) Prognosis and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 8:430–437
Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM (2002) Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46:436–444
Zonana-Nacach A, Barr SG, Magder LS, Petri M (2000) Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 43:1801–1808
Acknowledgments
All of the authors would like to express their thanks to Prof. med. Georg Schett for his expert assistance in preparation of the manuscript.
Disclosure
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lin, H., Wei, J.CC., Tan, Cy. et al. Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China. Clin Rheumatol 31, 1683–1689 (2012). https://doi.org/10.1007/s10067-012-2073-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-012-2073-6